-
1
-
-
0023757658
-
Epidemiology of dystonia in Rochester, Minnesota
-
Nutt JG, Muenter MD, Melton LJ, 3rd, et al. Epidemiology of dystonia in Rochester, Minnesota. Adv Neurol 1988; 50: 361-365
-
(1988)
Adv Neurol
, vol.50
, pp. 361-365
-
-
Nutt, J.G.1
Muenter, M.D.2
Melton III, L.J.3
-
2
-
-
0034917328
-
Health related quality of life is improved by botulinum neurotoxin type a in long term treated patients with focal dystonia
-
Hilker R, Schischniaschvili M, Ghaemi M, et al. Health related quality of life is improved by botulinum neurotoxin type a in long term treated patients with focal dystonia. J Neurol Neurosurg Psychiatry 2001; 71: 193-199
-
(2001)
J Neurol Neurosurg Psychiatry
, vol.71
, pp. 193-199
-
-
Hilker, R.1
Schischniaschvili, M.2
Ghaemi, M.3
-
3
-
-
0036651242
-
Impact of cervical dystonia on quality of life
-
Camfield L, Ben-Shlomo Y, Warner TT. Impact of cervical dystonia on quality of life. Mov Disord 2002; 17: 838-841
-
(2002)
Mov Disord
, vol.17
, pp. 838-841
-
-
Camfield, L.1
Ben-Shlomo, Y.2
Warner, T.T.3
-
4
-
-
0036240889
-
What are the determinants of quality of life in people with cervical dystonia?
-
Ben-Shlomo Y, Camfield L, Warner T. What are the determinants of quality of life in people with cervical dystonia? J Neurol Neurosurg Psychiatry 2002; 72: 608-614
-
(2002)
J Neurol Neurosurg Psychiatry
, vol.72
, pp. 608-614
-
-
Ben-Shlomo, Y.1
Camfield, L.2
Warner, T.3
-
5
-
-
0022337622
-
A pilot study on the use of botulinum toxin in spasmodic torticollis
-
Tsui JK, Eisen A, Mak E, et al. A pilot study on the use of botulinum toxin in spasmodic torticollis. Can J Neurol Sci 1985; 12: 314-316
-
(1985)
Can J Neurol Sci
, vol.12
, pp. 314-316
-
-
Tsui, J.K.1
Eisen, A.2
Mak, E.3
-
6
-
-
0022587865
-
Double-blind study of botulinum toxin in spasmodic torticollis
-
Tsui JK, Eisen A, Stoessl AJ, et al. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 1986; 2: 245-247
-
(1986)
Lancet
, vol.2
, pp. 245-247
-
-
Tsui, J.K.1
Eisen, A.2
Stoessl, A.J.3
-
7
-
-
0036869216
-
Long-term efficacy of botulinum toxin a in treatment of various movement disorders over a 10-year period
-
Hsiung GY, Das SK, Ranawaya R, et al. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Mov Disord 2002; 17: 1288-1293
-
(2002)
Mov Disord
, vol.17
, pp. 1288-1293
-
-
Hsiung, G.Y.1
Das, S.K.2
Ranawaya, R.3
-
8
-
-
14044254756
-
The course of cervical dystonia and patient satisfaction with long-term botulinum toxin a treatment
-
Skogseid IM, Kerty E. The course of cervical dystonia and patient satisfaction with long-term botulinum toxin a treatment. Eur J Neurol 2005; 12: 163-170
-
(2005)
Eur J Neurol
, vol.12
, pp. 163-170
-
-
Skogseid, I.M.1
Kerty, E.2
-
9
-
-
3042635460
-
Long-term follow-up of cervical dystonia patients treated with botulinum toxin A
-
Haussermann P, Marczoch S, Klinger C, et al. Long-term follow-up of cervical dystonia patients treated with botulinum toxin A. Mov Disord 2004; 19: 303-308
-
(2004)
Mov Disord
, vol.19
, pp. 303-308
-
-
Haussermann, P.1
Marczoch, S.2
Klinger, C.3
-
10
-
-
20844447349
-
Long-term botulinum toxin efficacy, safety, and immunogenicity
-
Mejia NI, Vuong KD, Jankovic J. Long-term botulinum toxin efficacy, safety, and immunogenicity. Mov Disord 2005; 20: 592-597
-
(2005)
Mov Disord
, vol.20
, pp. 592-597
-
-
Mejia, N.I.1
Vuong, K.D.2
Jankovic, J.3
-
11
-
-
0028803612
-
Response and immunoresistance to botulinum toxin injections
-
Jankovic J, Schwartz K. Response and immunoresistance to botulinum toxin injections. Neurology 1995; 45: 1743-1746
-
(1995)
Neurology
, vol.45
, pp. 1743-1746
-
-
Jankovic, J.1
Schwartz, K.2
-
12
-
-
0033957251
-
Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type a under EMG guidance. An open label study
-
Rollnik JD, Matzke M, Wohlfarth K, et al. Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type a under EMG guidance. An open label study. Eur Neurol 2000; 43: 9-12
-
(2000)
Eur Neurol
, vol.43
, pp. 9-12
-
-
Rollnik, J.D.1
Matzke, M.2
Wohlfarth, K.3
-
13
-
-
0031239673
-
Botulinum a toxin therapy: Neutralizing and nonneutralizing antibodies - Therapeutic consequences
-
Goschel H, Wohlfarth K, Frevert J, et al. Botulinum a toxin therapy: Neutralizing and nonneutralizing antibodies - therapeutic consequences. Exp Neurol 1997; 147: 96-102
-
(1997)
Exp Neurol
, vol.147
, pp. 96-102
-
-
Goschel, H.1
Wohlfarth, K.2
Frevert, J.3
-
14
-
-
33747161909
-
Botulinum toxin therapy for cervical dystonia
-
Jankovic J. Botulinum toxin therapy for cervical dystonia. Neurotox Res 2006; 9: 145-148
-
(2006)
Neurotox Res
, vol.9
, pp. 145-148
-
-
Jankovic, J.1
-
15
-
-
26444491206
-
Retrospective evaluation of the dose of dysport and botox in the management of cervical dystonia and blepharospasm: The real dose study
-
Marchetti A, Magar R, Findley L, et al. Retrospective evaluation of the dose of dysport and botox in the management of cervical dystonia and blepharospasm: The real dose study. Mov Disord 2005; 20: 937-944
-
(2005)
Mov Disord
, vol.20
, pp. 937-944
-
-
Marchetti, A.1
Magar, R.2
Findley, L.3
-
16
-
-
0032951652
-
Long-term treatment of cervical dystonia with botulinum toxin a: Efficacy, safety, and antibody frequency. German Dystonia Study Group
-
Kessler KR, Skutta M, Benecke R. Long-term treatment of cervical dystonia with botulinum toxin a: Efficacy, safety, and antibody frequency. German Dystonia Study Group. J Neurol 1999; 246: 265-274
-
(1999)
J Neurol
, vol.246
, pp. 265-274
-
-
Kessler, K.R.1
Skutta, M.2
Benecke, R.3
-
17
-
-
49249129595
-
Long-term therapy of focal dystonia and facial hemispasm with botulinum toxin a
-
Vogt T, Lussi F, Paul A, et al. [Long-term therapy of focal dystonia and facial hemispasm with botulinum toxin a]. Der Nervenarzt 2008; 79: 912-917
-
(2008)
Der Nervenarzt
, vol.79
, pp. 912-917
-
-
Vogt, T.1
Lussi, F.2
Paul, A.3
-
18
-
-
0037066095
-
Accuracy of muscle localization without EMG: Implications for treatment of limb dystonia
-
Molloy FM, Shill HA, Kaelin-Lang A, et al. Accuracy of muscle localization without EMG: Implications for treatment of limb dystonia. Neurology 2002; 58: 805-807
-
(2002)
Neurology
, vol.58
, pp. 805-807
-
-
Molloy, F.M.1
Shill, H.A.2
Kaelin-Lang, A.3
-
19
-
-
17844394143
-
Accuracy of intramuscular injection of botulinum toxin a in juvenile cerebral palsy: A comparison between manual needle placement and placement guided by electrical stimulation
-
Chin TY, Nattrass GR, Selber P, et al. Accuracy of intramuscular injection of botulinum toxin A in juvenile cerebral palsy: A comparison between manual needle placement and placement guided by electrical stimulation. J Pediatr Orthop 2005; 25: 286-291
-
(2005)
J Pediatr Orthop
, vol.25
, pp. 286-291
-
-
Chin, T.Y.1
Nattrass, G.R.2
Selber, P.3
-
20
-
-
0025886672
-
A double blind trial of botulinum toxin 'A' in torticollis, with one year follow up
-
Moore AP, Blumhardt LD. A double blind trial of botulinum toxin 'A' in torticollis, with one year follow up. J Neurol Neurosurg Psychiatry 1991; 54: 813-816
-
(1991)
J Neurol Neurosurg Psychiatry
, vol.54
, pp. 813-816
-
-
Moore, A.P.1
Blumhardt, L.D.2
-
21
-
-
24144445115
-
Efficacy and safety of botulinum type a toxin (dysport) in cervical dystonia: Results of the first us randomized, double-blind, placebo-controlled study
-
Truong D, Duane DD, Jankovic J, et al. Efficacy and safety of botulinum type a toxin (dysport) in cervical dystonia: Results of the first us randomized, double-blind, placebo-controlled study. Mov Disord 2005; 20: 783-791
-
(2005)
Mov Disord
, vol.20
, pp. 783-791
-
-
Truong, D.1
Duane, D.D.2
Jankovic, J.3
-
22
-
-
6844266275
-
What is the optimal dose of botulinum toxin a in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using dysport. German Dystonia Study Group
-
Poewe W, Deuschl G, Nebe A, et al. What is the optimal dose of botulinum toxin a in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using dysport. German Dystonia Study Group. J Neurol Neurosurg Psychiatry 1998; 64: 13-17
-
(1998)
J Neurol Neurosurg Psychiatry
, vol.64
, pp. 13-17
-
-
Poewe, W.1
Deuschl, G.2
Nebe, A.3
-
23
-
-
0027421580
-
Botulinum antibodies in dystonic patients treated with type a botulinum toxin: Frequency and significance
-
Zuber M, Sebald M, Bathien N, et al. Botulinum antibodies in dystonic patients treated with type a botulinum toxin: Frequency and significance. Neurology 1993; 43: 1715-1718
-
(1993)
Neurology
, vol.43
, pp. 1715-1718
-
-
Zuber, M.1
Sebald, M.2
Bathien, N.3
-
24
-
-
0028345811
-
Development of resistance to botulinum toxin type a in patients with torticollis
-
Greene P, Fahn S, Diamond B. Development of resistance to botulinum toxin type A in patients with torticollis. Mov Disord 1994; 9: 213-217
-
(1994)
Mov Disord
, vol.9
, pp. 213-217
-
-
Greene, P.1
Fahn, S.2
Diamond, B.3
-
25
-
-
0026787576
-
Stabilization of botulinum toxin type a during lyophilization
-
Goodnough MC, Johnson EA. Stabilization of botulinum toxin type A during lyophilization. Appl Environ Microbiol 1992; 58: 3426-3428
-
(1992)
Appl Environ Microbiol
, vol.58
, pp. 3426-3428
-
-
Goodnough, M.C.1
Johnson, E.A.2
-
26
-
-
0033378779
-
Preclinical update on Botox (botulinum toxin type a)-purified neurotoxin complex relative to other botulinum neurotoxin preparations
-
Aoki K. Preclinical update on Botox (botulinum toxin type a)-purified neurotoxin complex relative to other botulinum neurotoxin preparations. Eur J Neurol 1999; 6 (Suppl. 4): S3-S10
-
(1999)
Eur J Neurol
, vol.6
, Issue.SUPPL. 4
-
-
Aoki, K.1
-
27
-
-
0037426445
-
Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia
-
Jankovic J, Vuong KD, Ahsan J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology 2003; 60: 1186-1188
-
(2003)
Neurology
, vol.60
, pp. 1186-1188
-
-
Jankovic, J.1
Vuong, K.D.2
Ahsan, J.3
-
28
-
-
41249097564
-
Treatment of dystonia with deep brain stimulation
-
Ostrem JL, Starr PA. Treatment of dystonia with deep brain stimulation. Neurotherapeutics 2008; 5: 320-330
-
(2008)
Neurotherapeutics
, vol.5
, pp. 320-330
-
-
Ostrem, J.L.1
Starr, P.A.2
-
29
-
-
0000170999
-
Clinical assessments of patients with cervical dystonia
-
Jankovic J, Hallett M, eds. New York: Marcel Dekker
-
Consky ES, Lang AE. Clinical assessments of patients with cervical dystonia. In: Jankovic J, Hallett M, eds. Therapy with Botulinum Toxin, New York: Marcel Dekker, 1994: pp. 211-237
-
(1994)
Therapy with Botulinum Toxin
, pp. 211-237
-
-
Consky, E.S.1
Lang, A.E.2
|